ASP Isotopes Inc.
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
Item 5. Other Information.
Rule 10b5-1 Trading Plans
During the six months ended June 30, 2026, the following directors adopted trading arrangements intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act:
On June 30, 2026, Michael Gorley, a member of the Company’s board of directors, adopted a Rule 10b5-1 trading arrangement for the sale of up to 23,756 shares of the Company's common stock. The trading arrangement is scheduled to expire on December 18, 2026.
On June 30, 2026, Robert Ryan, a member of the Company’s board of directors, adopted a Rule 10b5-1 trading arrangement for the sale of up to 18,274 shares of the Company's common stock. The trading arrangement is scheduled to expire on December 18, 2026.
Other than the trading arrangements described above, no director or officer (as defined in Rule 16a-1(f) of the Exchange Act) of ours adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.